Clinical Trials Logo
  1. Home
  2. Generalized Anxiety
  3. NCT00390533

An Eight-week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety Disorder

Generalized Anxiety Clinical Trial

Official title:
An Eight-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study, to Evaluate the Efficacy, Safety and Tolerability of Two Fixed Doses (100 and 30 mg Once Daily) of Saredutant in Patients With Generalized Anxiety Disorder

Clinical Trial Summary

The primary objective is to evaluate the efficacy of two fixed doses (100 mg and 30 mg once daily) of saredutant compared to placebo in patients with generalized anxiety disorder. The secondary objectives are to evaluate the efficacy of saredutant on disability and quality of life in patients with generalized anxiety disorder, and to evaluate blood levels of saredutant.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00390533
Study type Interventional
Source Sanofi
Contact
Status Completed
Phase Phase 3
Start date September 2006
Completion date February 2008
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Recruiting NCT04702711 - Experiences of Anger in Patients in Primary Health Care With Symptoms of Generalized Anxiety
Active, not recruiting NCT04751864 - Brain Stimulation & Generalized Anxiety Study Phase 4
Completed NCT02678624 - Project Collabri for Treatment of Anxiety N/A
Active, not recruiting NCT04386291 - Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19 N/A
Completed NCT04356365 - The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's)
Not yet recruiting NCT04442360 - The Impact of Information Sources on Mental Health During the COVID-19 Pandemic
Not yet recruiting NCT04183946 - Willkommen Mutterglück: Online CBT for Pregnant and Postpartum Women With Depression and Anxiety N/A
Not yet recruiting NCT03445143 - GATE: Generalized Anxiety - A Treatment Evaluation N/A
Completed NCT03205332 - Training Mental Habits Study N/A
Not yet recruiting NCT04378257 - Efficacy of Therapist Guided e-Therapy Versus Self-Help Therapy on Psychological Distress Among Individuals in Oman During COVID-19 Pandemic Phase 3
Recruiting NCT03528109 - Improving Access to Child Anxiety Treatment N/A
Not yet recruiting NCT03015285 - CBT for Anxiety Sensitivity vs. Disorder-specific CBT: An RCT N/A
Completed NCT04510519 - Scaling Mental Healthcare in COVID-19 With Voice Biomarkers
Completed NCT00417118 - An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety Disorder Phase 3
Recruiting NCT06146530 - Cerina-A Pilot Randomized Controlled Trial N/A
Completed NCT02872051 - Integrated Mental Health Care and Vocational Rehabilitation to Individuals on Sick Leave Due to Anxiety and Depression N/A
Completed NCT02148042 - Overgeneralization of Conditioned Fear as a Pathogenic Marker of Anorexia Nervosa
Recruiting NCT05292807 - Imagery Rescripting and Imaginal Exposure for Anxiety Symptoms N/A